These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6156648)

  • 1. Antigenic relatedness of Proteus mirabilis and Escherichia coli with rat tissues and human erythrocytes.
    Kumar R; Vadehra DV; Mahajan RC
    Antonie Van Leeuwenhoek; 1980; 46(1):85-94. PubMed ID: 6156648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 response in cells from the human urinary tract induced by lipopolysaccharides of Proteus mirabilis O3 and O18.
    Chromek M; Stankowska D; Dadfar E; Kaca W; Rabbani H; Brauner A
    J Urol; 2005 Apr; 173(4):1381-4. PubMed ID: 15758809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
    Habibi M; Asadi Karam MR; Bouzari S
    Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorescent demonstration of bacterial antigen in experimental pyelonephritis with antiserum against common enterobacterial antigen.
    Thomsen OF; Hjort T
    Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):474-82. PubMed ID: 4205217
    [No Abstract]   [Full Text] [Related]  

  • 6. Different binding specificities of P. mirabilis compared to E. coli.
    Lomberg H; Larsson P; Leffler H; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():37-42. PubMed ID: 6753134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction.
    Yang P; Danielsson D; Järnerot G
    Scand J Gastroenterol; 1998 May; 33(5):529-34. PubMed ID: 9648994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conduiturinary diversion and urinary-tract infection. I. Serum antibody titers against Escherichia coli and Proteus mirabilis in relation to urographic findings.
    Bergman B; Kaijser K; Nilson AE
    Scand J Urol Nephrol; 1979; 13(1):65-70. PubMed ID: 368976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis.
    Legnani-Fajardo C; Zunino P; Algorta G; Laborde HF
    Can J Microbiol; 1991 Apr; 37(4):325-8. PubMed ID: 1680542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antigenic relationship between kidney and certain Escherichia coli strains.
    Holmgren J; Hanson LA; Holm SE; Kauser B
    Int Arch Allergy Appl Immunol; 1971; 41(2):463-74. PubMed ID: 5000357
    [No Abstract]   [Full Text] [Related]  

  • 11. An antigenic relationship between human kidney, colon and the common antigen of enterobacteriaceae.
    Holmgren J; Hammarström S; Holm SE; Ahlmén J; Attman PO; Jodal U
    Int Arch Allergy Appl Immunol; 1972; 43(1):89-97. PubMed ID: 4631662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological activity of different antigenic preparations of Proteus in precipitation tests].
    Omel'ianets' TG; Elshina MO; Open'ko LV; Dikhovichna DE; Lukch IG
    Mikrobiol Zh; 1975; 37(4):482-6. PubMed ID: 55948
    [No Abstract]   [Full Text] [Related]  

  • 13. Conduit urinary diversion and urinary-tract infection. II. Raised serum antibody titers against Escherichia coli and Proteus mirabilis in relation to bacteriologic findings.
    Bergman B; Kaijser B; Nilson AE
    Scand J Urol Nephrol; 1979; 13(1):71-7. PubMed ID: 368977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of an antigen cross-reacting with Escherichia coli -galactosidase.
    Erickson RP; Steers E
    Immunochemistry; 1972 Jan; 9(1):29-39. PubMed ID: 4625283
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes.
    Rashid T; Jayakumar KS; Binder A; Ellis S; Cunningham P; Ebringer A
    Clin Exp Rheumatol; 2007; 25(2):259-67. PubMed ID: 17543151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of Proteus mirabilis TG 115 and CCUG 10701 into the Proteus O23 serogroup based on chemical and serological studies of O-polysaccharides.
    Zabłotni A; Perepelov AV; Kołodziejska K; Zych K; Knirel YA; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(6):411-7. PubMed ID: 17122881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
    Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of two major proteins isolated from the outer membrane of Proteus mirabilis.
    Bub F; Bieker P; Martin HH; Nixdorff K
    Infect Immun; 1980 Feb; 27(2):315-21. PubMed ID: 6155331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet.
    Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; Førre O; Ebringer A
    Ann Rheum Dis; 1995 Mar; 54(3):221-4. PubMed ID: 7748020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.